GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review. [PDF]
Anastasiu CV +5 more
europepmc +1 more source
Editorial: Utilizing real-world evidence for better endocrine health management. [PDF]
Mei M, Lopes LC, Li C.
europepmc +1 more source
Endometriosis-associated bone loss: re-evaluating the potential role of systemic inflammation and hypoestrogenic therapies. [PDF]
Motafeghi F +3 more
europepmc +1 more source
Brief Report: Exploratory Substudy of a Phase 2 Trial to Evaluate the Pharmacokinetic Effect of Once-Monthly Islatravir on Long-Acting Reversible Contraceptives. [PDF]
Pham M +7 more
europepmc +1 more source
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084. [PDF]
Marzinke MA +21 more
europepmc +1 more source
Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain. [PDF]
Kim JH +5 more
europepmc +1 more source
Achieving Minimal-to-No Pain in Women with Endometriosis Treated with Relugolix Combination Therapy: SPIRIT Extension Trial. [PDF]
Lukes AS +8 more
europepmc +1 more source
Bone mineral density with elagolix plus add-back therapy in women with heavy menstrual bleeding and uterine fibroids: open-label and post-treatment results of a 60-month phase 3 trial. [PDF]
Schnell VL +6 more
europepmc +1 more source

